Jyothy Labs reported a 50.8% decline in net profit to ₹47.6 crore for Q1 FY27, weighed down by rising raw material costs and sluggish revenue growth. Operating margins nearly halved, leading to a negative market reaction as the stock dipped 5% following the result.
Jyothy Labs shares dropped by approximately 5% on August 13, 2026, following the company's disappointing first-quarter financial results for the 2027 fiscal year. The consumer goods maker reported a 50.8% plunge in net profit to ₹47.6 crore, as significantly higher raw material and packaging costs hit its bottom line hard.
Revenue growth remained modest at 3%, reaching ₹773.4 crore. While the company saw 8.1% value growth and 5.3% volume growth in its core portfolio (excluding the Pril and Fa brands), the overall financial performance failed to meet market expectations, keeping the stock trading near its 52-week lows.
Sharp Decline in Operating Margins
The most significant concern for investors was the company’s operating profit margin, which fell to 8.4% from 16.5% in the same quarter last year. This sharp decline was primarily driven by an unexpected spike in raw material and packaging costs. Management pointed to geopolitical tensions in West Asia as a major factor disrupting supply chains and inflating input costs.
Because the FMCG sector is highly competitive, Jyothy Labs found it difficult to pass these higher costs on to customers through price increases. This lack of pricing power in a rising-cost environment resulted in direct pressure on the company's profitability.
Strategic Challenges and Outlook
Beyond immediate cost pressures, the company is adjusting to a new business environment following the loss of the licensing deal for the Pril and Fa brands. This transition phase has introduced uncertainty regarding the stability of the company’s product mix and its ability to maintain consistent earnings visibility.
Despite the weak start to the year, company management remains optimistic about the remainder of the fiscal year. They are targeting double-digit sales growth for FY27, excluding the impact of the Pril brand. The company expects profit margins to recover gradually starting from the second half of the fiscal year, as it works to stabilize costs and seeks to improve its pricing strategy in a volatile market.
What Investors Should Monitor
For shareholders, the primary focus will be the company’s ability to protect and improve its margins in the coming quarters. Investors may want to track whether the company can successfully pass on costs to consumers or if raw material prices stabilize, as these factors will determine if the expected margin recovery in the second half of the year remains achievable. Additionally, any updates on market share and competition in the Home and Fabric Care segments will provide insight into how the company is managing its portfolio without its previous licensing arrangements.